Title of article :
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)
Author/Authors :
Meinertz، نويسنده , , Thomas and Lip، نويسنده , , Gregory Y.H and Lombardi، نويسنده , , Fedrico and Sadowski، نويسنده , , Zigmunt P and Kalsch، نويسنده , , Brigitte and Camez، نويسنده , , Anne and Hewkin، نويسنده , , Ann and Eberle، نويسنده , , Siegfried، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2002
Pages :
7
From page :
1300
To page :
1306
Abstract :
We report a double-blind, multicenter, multinational, placebo-controlled, and well-controlled trial to prove that the sustained-release (SR) formulation of propafenone is superior to placebo in preventing symptoms of paroxysmal atrial fibrillation (AF). A
Journal title :
American Journal of Cardiology
Serial Year :
2002
Journal title :
American Journal of Cardiology
Record number :
1894955
Link To Document :
بازگشت